Citylabs 2 Side View

Views sought on £60m Citylabs expansion

A public consultation is due to take place this afternoon, to gather views on Bruntwood’s proposed £60m extension of its Citylabs concept on Manchester’s Oxford Road.

The development of Citylabs 2.0 and 3.0 will total 205,000 sq ft, and forms the first project under a strategic property partnership with Central Manchester University Hospitals NHS Foundation Trust, announced earlier this year at MIPIM.

Designed by architect Sheppard Robson, Citylabs 2.0 and 3.0 will provide high-spec office, laboratory and collaboration space on the CMFT campus on Corridor Manchester.

The £25m Citylabs 2.0 totals 90,000 sq ft of labs and offices. Subject to planning permission being granted, construction work will begin in autumn 2017, with completion expected in late 2018.

Citylabs 3.0 will span 130,000 sq ft and integrate the development of new buildings with the Old St Mary’s Hospital, a listed Victorian building. Construction is planned to start in summer 2018 and is due to be completed in 2020.

The £35m project includes the restoration of a currently unused former chapel on the site, which is ear-marked for a café/dining area with the potential for meeting room facilities, as well as extensive external landscaping and the provision of new gardens for Citylabs occupiers and other users of the hospital facilities.

The development, a joint venture between Manchester Science Partnerships of which Bruntwood is the majority shareholder, and CMFT, will take the total built on the site to 300,000 sq ft following the construction of the 95,000 sq ft Citylabs 1.0, which was fully let shortly after opening in 2014. Citylabs 1.0 was a refurbishment and extension of the former Royal Eye Hospital.

Once complete, the three-part Citylabs complex will have a development value of £150m.

The drop-in exhibition takes place today between noon and 7pm at Citylabs 1.0, Nelson Street, Manchester, M13 9NQ.

Additional images of the proposals will be on display, and members of the development team will be available to answer any questions.

Your Comments

Read our comments policy here

Subscribe to our newsletter